Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Arend R, Dholakia J, Castro C, Matulonis U, Hamilton E, Jackson CG, LyBarger K, Goodman HM, Duska LR, Mahdi H, ElNaggar AC, Kagey MH, Liu A, Piper D, Barroilhet LM, Bradley W, Sachdev J, Sirard CA, O'Malley DM, Birrer M. Arend R, et al. Among authors: mahdi h. Gynecol Oncol. 2023 May;172:82-91. doi: 10.1016/j.ygyno.2023.03.013. Epub 2023 Mar 29. Gynecol Oncol. 2023. PMID: 37001446 Clinical Trial.
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.
Orr B, Mahdi H, Fang Y, Strange M, Uygun I, Rana M, Zhang L, Suarez Mora A, Pusateri A, Elishaev E, Kang C, Tseng G, Gooding W, Edwards RP, Kalinski P, Vlad AM. Orr B, et al. Among authors: mahdi h. Clin Cancer Res. 2022 May 13;28(10):2038-2049. doi: 10.1158/1078-0432.CCR-21-3659. Clin Cancer Res. 2022. PMID: 35046055 Free PMC article.
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer.
Coffman LG, Orellana TJ, Liu T, Frisbie LG, Normolle D, Griffith K, Uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards RP, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor SE, Buckanovich R. Coffman LG, et al. Among authors: mahdi h. JCI Insight. 2022 Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573. JCI Insight. 2022. PMID: 35972817 Free PMC article. Clinical Trial.
Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer.
Garrett AA, Wield A, Mumford B, Janmey I, Wang L, Grosse P, MacArthur E, Buckanovich R, Courtney-Brooks M, Sukumvanich P, Berger J, Olawaiye AB, Mahdi H, Boisen M, Edwards RP, Coffman L, Taylor SE, Lesnock J. Garrett AA, et al. Among authors: mahdi h. Gynecol Oncol Rep. 2022 Oct 7;44:101080. doi: 10.1016/j.gore.2022.101080. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36249905 Free PMC article.
The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
Orellana TJ, Garrett AA, Soong TR, Rives T, Courtney-Brooks M, Taylor SE, Lesnock J, Berger J, Boisen M, Coffman L, Buckanovich R, Mahdi H, Comerci JC, Beriwal S, Sukumvanich P, Edwards RP, Bhargava R, Olawaiye AB. Orellana TJ, et al. Among authors: mahdi h. Gynecol Oncol. 2023 Mar;170:77-83. doi: 10.1016/j.ygyno.2022.12.024. Epub 2023 Jan 13. Gynecol Oncol. 2023. PMID: 36641903
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression.
Pavicic PG Jr, Rayman PA, Swaidani S, Rupani A, Makarov V, Tannenbaum CS, Edwards RP, Vlad AM, Diaz-Montero CM, Mahdi H. Pavicic PG Jr, et al. Among authors: mahdi h. Oncoimmunology. 2023 Apr 10;12(1):2198185. doi: 10.1080/2162402X.2023.2198185. eCollection 2023. Oncoimmunology. 2023. PMID: 37066116 Free PMC article.
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors.
Wang X, Barrera C, Bera K, Viswanathan VS, Azarianpour-Esfahani S, Koyuncu C, Velu P, Feldman MD, Yang M, Fu P, Schalper KA, Mahdi H, Lu C, Velcheti V, Madabhushi A. Wang X, et al. Among authors: mahdi h. Sci Adv. 2022 Jun 3;8(22):eabn3966. doi: 10.1126/sciadv.abn3966. Epub 2022 Jun 1. Sci Adv. 2022. PMID: 35648850 Free PMC article.
186 results